UNLABELLED: We evaluated the long-term excess mortality associated with hip fracture, using prospectively collected data on pre-fracture health and function from a nationally representative sample of U.S. elders. Although mortality was elevated for the first six months following hip fracture, we found no evidence of long-term excess mortality. INTRODUCTION: The long-term excess mortality associated with hip fracture remains controversial. METHODS: To assess the association between hip fracture and mortality, we used prospectively collected data on pre-fracture health and function from a representative sample of U.S. elders in the Medicare Current Beneficiary Survey (MCBS) to perform survival analyses with time-varying covariates. RESULTS: Among 25,178 MCBS participants followed for a median duration of 3.8 years, 730 sustained a hip fracture during follow-up. Both early (within 6 months) and subsequent mortality showed significant elevations in models adjusted only for age, sex and race. With additional adjustment for pre-fracture health status, functional impairments, comorbid conditions and socioeconomic status, however, increased mortality was limited to the first six months after fracture (hazard ratio [HR]: 6.28, 95% CI: 4.82, 8.19). No increased mortality was evident during subsequent follow-up (HR: 1.04, 95% CI: 0.88, 1.23). Hip-fracture-attributable population mortality ranged from 0.5% at age 65 among men to 6% at age 85 among women. CONCLUSIONS: Hip fracture was associated with substantially increased mortality, but much of the short-term risk and all of the long-term risk was explained by the greater frailty of those experiencing hip fracture.
UNLABELLED: We evaluated the long-term excess mortality associated with hip fracture, using prospectively collected data on pre-fracture health and function from a nationally representative sample of U.S. elders. Although mortality was elevated for the first six months following hip fracture, we found no evidence of long-term excess mortality. INTRODUCTION: The long-term excess mortality associated with hip fracture remains controversial. METHODS: To assess the association between hip fracture and mortality, we used prospectively collected data on pre-fracture health and function from a representative sample of U.S. elders in the Medicare Current Beneficiary Survey (MCBS) to perform survival analyses with time-varying covariates. RESULTS: Among 25,178 MCBS participants followed for a median duration of 3.8 years, 730 sustained a hip fracture during follow-up. Both early (within 6 months) and subsequent mortality showed significant elevations in models adjusted only for age, sex and race. With additional adjustment for pre-fracture health status, functional impairments, comorbid conditions and socioeconomic status, however, increased mortality was limited to the first six months after fracture (hazard ratio [HR]: 6.28, 95% CI: 4.82, 8.19). No increased mortality was evident during subsequent follow-up (HR: 1.04, 95% CI: 0.88, 1.23). Hip-fracture-attributable population mortality ranged from 0.5% at age 65 among men to 6% at age 85 among women. CONCLUSIONS:Hip fracture was associated with substantially increased mortality, but much of the short-term risk and all of the long-term risk was explained by the greater frailty of those experiencing hip fracture.
Authors: Bahman Y Farahmand; Karl Michaëlsson; Anders Ahlbom; Sverker Ljunghall; John A Baron Journal: Osteoporos Int Date: 2005-10-11 Impact factor: 4.507
Authors: Marlene Fransen; Mark Woodward; Robyn Norton; Elizabeth Robinson; Meg Butler; A John Campbell Journal: J Am Geriatr Soc Date: 2002-04 Impact factor: 5.562
Authors: Barbra S Miller; Kathleen M Ignatoski; Stephanie Daignault; Ceit Lindland; Megan Doherty; Paul G Gauger; Gary D Hammer; Stewart C Wang; Gerard M Doherty Journal: World J Surg Date: 2012-07 Impact factor: 3.352
Authors: Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie Journal: CMAJ Date: 2010-10-12 Impact factor: 8.262
Authors: S M Solbakken; H E Meyer; H Stigum; A J Søgaard; K Holvik; J H Magnus; T K Omsland Journal: Osteoporos Int Date: 2016-10-07 Impact factor: 4.507
Authors: Stephen K Liu; Jeffrey C Munson; John-Erik Bell; Rebecca L Zaha; John N Mecchella; Anna N A Tosteson; Nancy E Morden Journal: J Am Geriatr Soc Date: 2013-10-28 Impact factor: 5.562
Authors: M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; Y Sato; J S Moon; A Harano; K Hazaki; E Kajita; M Hamada; K Arai; K Tomioka; N Okamoto; N Kurumatani Journal: Osteoporos Int Date: 2016-10-18 Impact factor: 4.507
Authors: E Lönnroos; H Kautiainen; R Sund; P Karppi; S Hartikainen; I Kiviranta; R Sulkava Journal: Osteoporos Int Date: 2008-09-23 Impact factor: 4.507
Authors: Christopher J Dy; Joseph M Lane; Ting Jung Pan; Michael L Parks; Stephen Lyman Journal: J Bone Joint Surg Am Date: 2016-05-18 Impact factor: 5.284
Authors: Vibeke Juliebø; Maria Krogseth; Eva Skovlund; Knut Engedal; Torgeir B Wyller Journal: J Gerontol A Biol Sci Med Sci Date: 2009-12-18 Impact factor: 6.053